CAS 2749298-36-8
:Haloperidol Decanoate N-Oxide
Description:
Haloperidol Decanoate N-Oxide is a derivative of haloperidol, an antipsychotic medication primarily used to treat schizophrenia and acute psychosis. This compound is characterized by its long-acting formulation, which allows for extended therapeutic effects compared to its parent drug. The N-oxide modification enhances its pharmacokinetic properties, potentially influencing its solubility and bioavailability. Haloperidol Decanoate N-Oxide is typically administered via intramuscular injection, providing a sustained release of the active ingredient over time. The compound exhibits a high affinity for dopamine receptors, particularly D2 receptors, which is central to its mechanism of action in managing psychotic disorders. Additionally, it may have varying side effects, including extrapyramidal symptoms, sedation, and metabolic changes, similar to other antipsychotics. As with any pharmaceutical, careful consideration of dosage and patient monitoring is essential to optimize therapeutic outcomes while minimizing adverse effects. Further research may be necessary to fully elucidate its pharmacological profile and potential clinical applications.
Formula:C31H41ClFNO4
Synonyms:- Haloperidol Decanoate N-Oxide
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 1 products.
